Deutsche Bank
DRUG

Deutsche Bank’s Bright Minds Biosciences DRUG Stock Holding History

Deutsche Bank’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$548K Buy
7,808
+1,550
+25% +$122K ﹤0.01% 2721
2026
Q1 		$457K Buy
6,258
+1,999
+47% +$161K ﹤0.01% 2616
2025
Q4 		$332K Buy
4,259
+3,640
+588% +$243K ﹤0.01% 2777
2025
Q3 		$37.5K Sell
619
-4,867
-89% -$189K ﹤0.01% 3460
2025
Q2 		$143K Buy
+5,486
New +$164K ﹤0.01% 3112

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Deutsche Bank's DRUG Position: Q2 2026 in Review

Deutsche Bank increased its Bright Minds Biosciences (DRUG) stake by 25% in Q2 2026, buying an estimated $122K and bringing the position to 7,808 shares worth $548K. The position accounts for ﹤0.01% of the portfolio, ranked #2721.

Deutsche Bank first reported a position in DRUG in Q2 2025 and has held it in 5 quarters since. 99 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Deutsche Bank held 7,808 shares of Bright Minds Biosciences worth $548K as of Q2 2026.
  • Deutsche Bank bought 1,550 Bright Minds Biosciences shares in Q2 2026, an estimated $122K.
  • Bright Minds Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2721 holding.
  • Deutsche Bank first reported a position in Bright Minds Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 99 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.